A Phase 3, Multi-center, Randomized, Double-Blind, Vehicle-controlled Study to Evaluate the Efficacy and Safety of Topical Administration of Minocycline Hydrochloride Foam (4%) in the Treatment of Moderate-to-Severe Acne Vulgaris
This is a randomized, multicenter, double-blind, vehicle-controlled, 2-arm study to evaluate the safety and efficacy in 12 weeks of FMX101 minocycline foam, 4%, compared to vehicle, in the treatment of subjects with moderate to severe facial acne vulgaris.
100 Clinical Results associated with Cutia Therapeutics (Shanghai) Co., Ltd.
0 Patents (Medical) associated with Cutia Therapeutics (Shanghai) Co., Ltd.
100 Deals associated with Cutia Therapeutics (Shanghai) Co., Ltd.
100 Translational Medicine associated with Cutia Therapeutics (Shanghai) Co., Ltd.